BTK signaling is also an essential regulator of the pro-inflammatory process in the lungs, which makes disrupting BTK a promising strategy against chronic pulmonary inflammatory diseases, including chronic obstructive pulmonary disease and asthma [332]. Here, BTK is linked to chronic obstructive pulmonary disease.